Alcon sells Kaysersberg Pharmaceuticals to Recipharm
Clients Laboratoires Alcon
Jones Day advised Alcon, a Novartis company, in its sale of Kaysersberg Pharmaceuticals to Recipharm AB.
Cases & Deals
Contacts
Before sending, please note:
Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.